期刊文献+

聚集素在非小细胞肺癌中的表达及意义 被引量:4

Expression and significance of Clusterin in non-small cell lung cancer
下载PDF
导出
摘要 目的通过检测聚集素(Clusterin)在正常支气管黏膜上皮、非小细胞肺癌(NSCLC)组织中的表达,探讨其与肺癌发生发展的关系。方法采用免疫组化染色法检测16例正常支气管黏膜上皮组织、53例非小细胞肺癌组织标本中Clusterin的表达水平。结果Clusterin在正常支气管黏膜上皮、肺癌组织中阳性表达率分别为12.50%(2/16)、79.25%(42/53)。肺癌组织中Clusterin表达水平明显高于正常支气管黏膜上皮组织(χ2=23.68,P<0.05),且在癌组织中的表达与肿瘤的分化程度(rs=0.464,P<0.001)、临床分期(rs=0.320,P<0.01)及有无淋巴结转移(rs=0.255,P<0.05)呈正相关。结论Clusterin在非小细胞肺癌中高表达且与其临床特征相关。 Objective To investigate the expression and significance of Clusterin in normal epithelia of bronchial mucosa and tissues of non-small cell lung cancer. Methods Clusterin expression in cases of 16 normal epithelia of bronchial mucosa and tissues of 53 non-small cell lung cancer were detected by immunohistochemical stain. Results The rate of positive expression for normal epithelia of bronchial mucosa and tissues of non-small cell lung cancer was 12.50% (2/16) and 79.25% (42/53), respectively. The expression level of Clusterin in non-small cell lung cancer was much higher than that in normal epithelia of bronchial mucosa (x^2 = 23.68, P 〈 0.05) and it was related positively with pathological differentiation(rs = 0.464, P 〈 0.001 ), clinical stage(rs = 0. 320, P 〈 0.01 ) and lymph node metastasis(rs = 0. 255, P 〈 0.05) of non-small cell lung cancer. Conclusion Clusterin expressed highly in non-small cell lung cancer, but overexpressed of Clusterin had significant relationship with clinical characteristics.
出处 《哈尔滨医科大学学报》 CAS 北大核心 2006年第3期201-203,共3页 Journal of Harbin Medical University
基金 黑龙江省科委重大攻关课题(GB05C401-07)
关键词 非小细胞肺癌 聚集素 凋亡 免疫组织化学 non-small cell lung cancer Clusterin apoptosis immunohistoehemstry
  • 相关文献

参考文献3

二级参考文献30

  • 1Sintich S M, Steinberg J, Kozlowski J M, et al. Cytotoxic sensitivity to tumor necrosis factor-alpha in PC3 and LNCaP prostatic cancer cells is regulated by extracellular levels of SGP-2(clusterin) [J]. Prostate, 1999, 39(2): 87-93.
  • 2Steinberg I, Oyasu R, Lang S, et al. Intracellular levels of SGP-2 (Clusterin) correlate with tumor grade in prostate cancer[J]. Clin Cancer Res,1997, 3(10): 1707- 1711.
  • 3Mikata K, Uemura H, Ohuchi H, et al. Inhibition of growth of human prostate cancer xenograft by transfection of 153 gene: gene transfer by electroporation[J]. Mol Cancer Ther, 2002, 1(4): 247-252.
  • 4Gleave M, Tolcher A, Miyake H, et al. Progression to androgen independence is delayed by adjuvant treatment with antisene Bcl-2 oligodeoxynucleotides after castration in the LNCaP prostate tumor model [ J]. Clin Cancer Res, 1999, 5(10): 2891- 2898.
  • 5Miyake H, Nelson C, Rennie P S, et al. Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer[ J]. Cancer Res, 2000, 60( 1 ): 170- 176.
  • 6Gleave M E, Miyake H, Zellweger T, et al. Use of antisense oligonucleotides targeting the antiapoptotic gene, Clusterin/testosterone-repressed prostate message 2 to enhance androgen sensitivity and chemosensitivity in prostate cancer[J]. Urology, 2001, 58
  • 7Ohira T, Akutagawa S, Usuda J, Nakamura T, Hirano T, TsuboiM. Up-regulated gene expression of angiogenesis factors in postchemotherapeutic lung cancer tissues determined by cDNA macroarray. Oncol Rep 2002; 9: 723-8.
  • 8Califano A, Stolovitzky G, Tu Y. Analysis of gene expression microarrays for phenotype classification. Proc Int Conf Intell Syst Mol Biol 2000; 8: 75-85.
  • 9Shimoyama Y, Kubota T, Watanabe M, Ishibiki K, Abe O. Predictability of in vivo chemosensitivity by in vitro MTT assay with reference to the clonogenicassay. J Surg Oncol 1989; 41:12-8.
  • 10Reed LJ, Muench HA. Simple method of estimating fifty percent end points. Am J Hyg 1938; 27: 493.

共引文献17

同被引文献48

  • 1罗俊航,谢丹,陈炜,戴宇平,李晓飞,陶瑜,郑克立.clusterin表达与膀胱癌预后的关系[J].癌症,2005,24(6):743-747. 被引量:14
  • 2赵晓航,何洪智,王堃,张自森,滕梁红,周兰萍,刘芳,曲佳.食管鳞癌中clusterin的糖基化修饰和表达定位改变[J].第二军医大学学报,2005,26(12):1333-1336. 被引量:5
  • 3渠武帅,段建敏,秦大山,岳中谨,王志平,王青兵,史庭楷.c-FLIP/BCL-2/Ki-67在膀胱移行细胞癌中的表达与临床病理学特征及对预后影响的研究[J].中国现代医学杂志,2006,16(9):1353-1357. 被引量:3
  • 4熊茂明,钱福永,李贺,孟翔凌,耿小平,曹立宇.原发性肝癌中Clusterin异常表达与多药耐药关系的研究[J].肝胆外科杂志,2007,15(1):34-38. 被引量:11
  • 5Pucci S,Bonanno E,Pichiorri F,et al.Modulation of different clusterin isoforms in human colon tumorigenesis[J].Oncogene,2004,23(13):2 298-2 304.
  • 6Sun B,Zhang S,Zhang D,et al.Clusterin is associated with spontaneous breast cancer in TA2 mice[J].FEBS Lett,2007,581(17):3 277-3282.
  • 7Chen Y,Lim BK,Peh SC,et al.Profiling of serum and tissue high abundance acute-phase proteins of patients with epithdial and germ line ovarian carcinoma[J].Proteome Sci,2008,6(1):20.
  • 8Chayka O,Corvetta D,Dews M,et al.Clusterin,a haploinsufficient tumor suppressor gene in neuroblastomas[J].J Nail Cancer Inst,2009,101(9):663-677.
  • 9Zhong B,Sallman DA,Gilvary DL,et al.Induction of clusterin by AKT-role in cytoprotection against docetaxel in prostate tumor cells[J].Mol Cancer Ther,2010,9(6):1831-1841.
  • 10Blaschuk O,Burdzy K,Fritz lB.Purification and characterization of a cell-aggregating factor(clusterin),the major glycoprotein in ram rete testis fluid[J].J Biol Chem,1983,258(12):7714-7720.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部